IQE: VCSEL Growth Underpins Revenue Upgrade

 | Jan 02, 2018 07:07AM ET

International Quantum Epitaxy (LON:IQE)’s pre-close trading update noted that management expects FY17 revenues to be ahead of market expectations. Noting that the upgrade is driven by delivery of volume epitaxy on a programme that we infer is the new iPhone X, a programme which will continue throughout FY18, we raise our revenue estimates for both FY17 and FY18, but keep EPS numbers unchanged as the proportion of licence revenues in the mix is lower.